Is SAIC overvalued or undervalued?

At $132.96 the price sits below every lens we ran. We don't call SAIC overvalued or undervalued from a range. This is an educational estimate, not advice.

What discount rate is used for SAIC?

A WACC of 7.8% and a terminal growth rate of 2.5%.

Is Science Applications International stock undervalued?

TickerWorth's fair-value range for Science Applications International Corporation (SAIC) is $157.21 – $295.93 against a market price of $132.96. Priced below our range. We publish a range here, not one number, so we do not call it over- or undervalued. This is a model estimate, not investment advice.

Science Applications International (SAIC) DCF valuation and fair value

Our fair-value range for Science Applications International Corporation (SAIC) is $157.21 – $295.93, built on a 7.8% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.

What growth is priced into Science Applications International stock?

Today's price implies revenue growth of −2.6% a year for 5 years; our model assumes 1.4% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of $132.96. A model estimate, not investment advice.

Science Applications International (SAIC) insider trading

The most recent insider filing (SEC Form 4) for Science Applications International Corporation (SAIC): Cush C. David, Director, open-market buy on 2026-09-22. The latest filings are listed on this page. A disclosure, not a signal to trade.

SAIC · Intrinsic value

Is Science Applications International Corporation (SAIC) overvalued or undervalued?

Name: Science Applications International Corporation (SAIC) DCF intrinsic value
Creator: TickerWorth

As of Oct 19, 2026, TickerWorth publishes a fair-value range of $157.21 – $295.93 for Science Applications International Corporation (SAIC), against the delayed market price of $132.96: priced below our range. It is a range, not a single number, so we do not call it over- or undervalued. It is a model estimate; every input is sourced below.

Model by Miraaj Patel · generated from a hand-researched model · Updated Oct 19, 2026 · How these pages are made

Open full SAIC analysis

What is SAIC worth?

Backup data source

This price comes from our backup market-data feed.

Fair-value range: $157.21 – $295.93; A range by design: peer multiples and our researched mid-cycle DCF.
Market price: $132.96
Gap to fair value: —
Verdict: Priced below our range

Price as of 19 Oct 2026, 14:38 UTC · Prices are delayed.We publish this company as a range by design, not because our valuation lenses disagree, and we do not collapse it to a single number. We do not call it over- or undervalued from a range.

Fair-value range against the delayed market price: Priced below our range.

Reverse DCF: Today's price implies revenue growth of −2.6% a year for 5 years; our model assumes 1.4% a year on average over the same horizon.

What is SAIC's TickerWorth Score?

B57/100

Cheap against our estimate — but a weaker business

Compared with Technology companies in US

Its strongest point: looks cheap on the numbers. Its weakest: balance sheet looks stretched.

Value · 83 of 100
Cheaper than 83% of Technology companies in US
Price vs worth · 100 of 100
Quality · 37 of 100
More profitable than 37% of Technology companies in US
Financial health · 15 of 100
Financially stronger than 15% of Technology companies in US
Growth · 18 of 100
Growing faster than 18% of Technology companies in US
Momentum · 84 of 100
Outperformed 84% of Technology companies in US over the past year

Confidence: High confidence · Scored 19 Oct 2026, 14:38 UTC

Get the Undervalued Company of the Week.

Where the numbers come from

Hand-researched model

What the modeller flagged

TERMINAL VALUE IS ~79% OF ENTERPRISE VALUE — above the 75% line, because the WACC is low (7.77%). The WACC x terminal-growth grid runs from ~$92 to ~$339, so the precision of the per-share figure is spurious.
YEAR-1 FCF (~$459M UNLEVERED) IS ~20% BELOW FY2026's REPORTED $577M AND WELL BELOW THE >$600M GUIDE — right at the 20% line. The model is deliberately less generous than SAIC's own measure: it keeps ~$126M of non-cash intangible amortization and ~$60M of stock compensation as costs, and taxes EBIT at a normalised 20% when SAIC paid only $22M of cash tax in FY2026. Adding back amortization alone gives $189.96.
THE GROWTH RECOVERY IS THE BIG ASSUMPTION THE MARKET DOUBTS. SAIC's revenue was $7,444M three years ago and is guided to $7,250M this year; trailing book-to-bill is 0.8. If revenue simply stays flat after FY2028 (no 2-3% recovery), the value is $144.55; to justify today's price on this model's margins, revenue would have to shrink ~2.6% a year for five years.
MARGINS LEAN ON MANAGEMENT'S PROJECT ORBIT TARGETS, haircut. Taking the ~11% FY2030 adjusted EBITDA target in full gives $161.63; if margins never rise above FY2027's 8.0% GAAP level, $136.98; back at FY2026's 7.17%, $116.20 — below the price.
Beta is normalized UP from the published 0.31 to 0.72 (10-year regression 0.59, Blume-adjusted, the same final beta as LDOS), and cost of debt uses the ~7.0% marginal rate rather than the ~5% coupon average. Both LOWER the value; the published 0.31 beta alone gives $234.27 — that single input explains most of the gap to TickerWorth's automatic model.
Net debt is the 2026-07-31 balance and includes the $164M of sold receivables. SAIC's ~$1.1B of tax attributes (NOLs and tax-deductible goodwill/intangibles from past deals, per the 10-K, subject to Section 382 limits) are not credited separately; the 20% normalised rate already sits below the statutory rate.

Why SAIC gets a range, not one number

At a recent price of $132.96, Science Applications International Corporation (SAIC) sits below every lens we ran: our valuation lenses put the business somewhere between $157.21 and $295.93 per share. For a cyclical we value through the cycle we publish a range only (peer multiples and our researched mid-cycle DCF): where in the cycle the business sits decides where in that range it lands, and a single figure would claim we know that precisely. This is an educational model, not a price target or a recommendation.

Read the full reasoning

The valuation discounts Science Applications International Corporation's projected free cash flows at a weighted-average cost of capital (WACC) of 7.8%, with a long-run terminal growth rate of 2.5%. About 79% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.

Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly -2.6% annual revenue growth for SAIC. Our base case instead compounds to about 1.4% a year over the same forecast, so the market is pricing in slower growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.

Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, SAIC's modeled DCF value ranges from about $92.02 to $339.13 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.

How to read this page: the DCF fair value is what Science Applications International Corporation would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of SAIC's intrinsic value. Figures update as new filings and prices come in.

Every input behind SAIC's DCF

Input	Value	Source
Base-year revenueSAIC FY2026 10-K (accession 0001571123-26-000029, filed 2026-03-16), fiscal year ended 2026-01-30: Revenues $7,262M for the 52 weeks to 2026-01-30 (SAIC's fiscal year ends on the Friday closest to 31 January, so 'FY2026' is mostly calendar 2025). DOWN 2.9% on FY2025's $7,479M; organic -3.3% excluding the SilverEdge acquisition ($27M). Revenue has now gone nowhere for three years: $7,444M (FY2024), $7,479M (FY2025), $7,262M (FY2026). 98% of revenue is U.S. government (52% Department of War, 46% intelligence and other federal agencies); 62% cost-reimbursable, 22% time-and-materials, 16% fixed-price. CROSS-CHECK: H1 FY2027 revenue $3,786M, +3.8% on H1 FY2026 ($3,646M), of which ~1 point is SilverEdge; Q2 organic growth 5.3%. Management guides the second half DOWN because the RITS contract rolls off (see forecast).	$7,262,000,000	SAIC FY2026 10-K (accession 0001571123-26-000029, filed 2026-03-16), fiscal year ended 2026-01-30: Revenues $7,262M for the 52 weeks to 2026-01-30 (SAIC's fiscal year ends on the Friday closest to 31 January, so 'FY2026' is mostly calendar 2025). DOWN 2.9% on FY2025's $7,479M; organic -3.3% excluding the SilverEdge acquisition ($27M). Revenue has now gone nowhere for three years: $7,444M (FY2024), $7,479M (FY2025), $7,262M (FY2026). 98% of revenue is U.S. government (52% Department of War, 46% intelligence and other federal agencies); 62% cost-reimbursable, 22% time-and-materials, 16% fixed-price. CROSS-CHECK: H1 FY2027 revenue $3,786M, +3.8% on H1 FY2026 ($3,646M), of which ~1 point is SilverEdge; Q2 organic growth 5.3%. Management guides the second half DOWN because the RITS contract rolls off (see forecast).
Base EBIT marginSAIC FY2026 10-K (accession 0001571123-26-000029): GAAP operating income $521M / revenue $7,262M = 7.17%, as reported. It is AFTER $119M of acquired-intangible amortization, $16M of executive-transition costs (the CEO departed in Q3 FY2026; Jim Reagan, interim, was made permanent in February 2026), $7M of federal tax-audit settlement costs and $10M net of acquisition/restructuring costs — about $33M (0.45 points) of items SAIC calls non-recurring. Its own adjusted operating margin (which also excludes amortization and depreciation) was 9.7%. Earlier years are NOT a cleaner base: FY2024's 10.0% included a $240M gain on divestitures. CROSS-CHECK: H1 FY2027 GAAP operating margin 8.7% ($331M / $3,786M), helped by a $12M gain on the sale of an investment; Q2 alone 8.1%.	7.2%	SAIC FY2026 10-K (accession 0001571123-26-000029): GAAP operating income $521M / revenue $7,262M = 7.17%, as reported. It is AFTER $119M of acquired-intangible amortization, $16M of executive-transition costs (the CEO departed in Q3 FY2026; Jim Reagan, interim, was made permanent in February 2026), $7M of federal tax-audit settlement costs and $10M net of acquisition/restructuring costs — about $33M (0.45 points) of items SAIC calls non-recurring. Its own adjusted operating margin (which also excludes amortization and depreciation) was 9.7%. Earlier years are NOT a cleaner base: FY2024's 10.0% included a $240M gain on divestitures. CROSS-CHECK: H1 FY2027 GAAP operating margin 8.7% ($331M / $3,786M), helped by a $12M gain on the sale of an investment; Q2 alone 8.1%.
Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast	-0% → -1% → 2% → 3% → 3%	ESTIMATEAssumption — TickerWorth's 5-year explicit forecast
Risk-free rateUS 10Y Treasury constant maturity (FRED DGS10): 5.24% on 2026-10-01, the latest published observation; shared by every researched model in this tracker.	5.2%	US 10Y Treasury constant maturity (FRED DGS10): 5.24% on 2026-10-01, the latest published observation; shared by every researched model in this tracker.
BetaESTIMATEAssumption — yfinance published beta (5Y monthly) 0.309; own 10-year monthly regression 0.589, Blume-adjusted: NORMALIZED UP from the published 0.31 to 0.72 — this LOWERS the value. Two steps, one from each peer file. (1) The HII test: at 0.31 SAIC's cost of equity would be 6.8%, BELOW the ~7.0% it would pay on a new unsecured bond — equity cannot be cheaper than the company's own debt — so, as for HII, the anchor is my own 10-year monthly regression against the S&P 500 (yfinance adjusted closes, Nov 2016-Oct 2026): 0.589. The 5-year gives 0.30, the 3-year -0.17 and a 2-year weekly 0.37: budget-driven contractors barely co-move with the market (peers on the same feed: BAH 0.37, KBR 0.47, LDOS 0.59, CACI 0.59, PSN 0.71). (2) The LDOS step: Blume adjustment (0.67 x 0.589 + 0.33 = 0.72), the same final beta as Leidos, because SAIC is MORE levered (net leverage 3.0x per management on the Q2 call; its term loans are secured and its newest notes carry high-yield-style call protection) and has shrunk three years running. Cost of equity 8.84%, ~180bp above the new-debt rate — the gap the HII/KO/PEP/PG files carry. Sensitivity: the unadjusted 0.589 gives $176.83; the Blume-adjusted published beta (0.54) $185.89; the published 0.31 $234.27.	0.72	ESTIMATEAssumption — yfinance published beta (5Y monthly) 0.309; own 10-year monthly regression 0.589, Blume-adjusted: NORMALIZED UP from the published 0.31 to 0.72 — this LOWERS the value. Two steps, one from each peer file. (1) The HII test: at 0.31 SAIC's cost of equity would be 6.8%, BELOW the ~7.0% it would pay on a new unsecured bond — equity cannot be cheaper than the company's own debt — so, as for HII, the anchor is my own 10-year monthly regression against the S&P 500 (yfinance adjusted closes, Nov 2016-Oct 2026): 0.589. The 5-year gives 0.30, the 3-year -0.17 and a 2-year weekly 0.37: budget-driven contractors barely co-move with the market (peers on the same feed: BAH 0.37, KBR 0.47, LDOS 0.59, CACI 0.59, PSN 0.71). (2) The LDOS step: Blume adjustment (0.67 x 0.589 + 0.33 = 0.72), the same final beta as Leidos, because SAIC is MORE levered (net leverage 3.0x per management on the Q2 call; its term loans are secured and its newest notes carry high-yield-style call protection) and has shrunk three years running. Cost of equity 8.84%, ~180bp above the new-debt rate — the gap the HII/KO/PEP/PG files carry. Sensitivity: the unadjusted 0.589 gives $176.83; the Blume-adjusted published beta (0.54) $185.89; the published 0.31 $234.27.
Terminal growthESTIMATEAssumption — house default: House default 2.5% (roughly long-run nominal GDP), kept for comparability and the same as the LDOS file. It is NOT conservative for this company: SAIC's revenue was $7.4B in FY2024 and is guided to $7.25B in FY2027, so 2.5% forever assumes it eventually grows with federal technology spending rather than continuing to lose share. 2.0% gives $141.74; the market price implies ~1.4% (holding everything else). Must remain < WACC of ~7.77%.	2.5%	ESTIMATEAssumption — house default: House default 2.5% (roughly long-run nominal GDP), kept for comparability and the same as the LDOS file. It is NOT conservative for this company: SAIC's revenue was $7.4B in FY2024 and is guided to $7.25B in FY2027, so 2.5% forever assumes it eventually grows with federal technology spending rather than continuing to lose share. 2.0% gives $141.74; the market price implies ~1.4% (holding everything else). Must remain < WACC of ~7.77%.
Diluted sharesSAIC Q2 FY2027 10-Q (accession 0001571123-26-000133, filed 2026-08-31): Q2 FY2027 weighted-average diluted shares 42.8M (H1 43.4M; FY2026 46.5M; FY2025 50.5M). The count is falling FAST: $286M of stock bought back or withheld in H1 FY2027 after $445M in FY2026, under a $1.2B authorization from December 2024. 41,897,635 shares were outstanding at the 10-Q cover date, so the 42.8M used is a little conservative. No credit is given for future buybacks.	43M	SAIC Q2 FY2027 10-Q (accession 0001571123-26-000133, filed 2026-08-31): Q2 FY2027 weighted-average diluted shares 42.8M (H1 43.4M; FY2026 46.5M; FY2025 50.5M). The count is falling FAST: $286M of stock bought back or withheld in H1 FY2027 after $445M in FY2026, under a $1.2B authorization from December 2024. 41,897,635 shares were outstanding at the 10-Q cover date, so the 42.8M used is a little conservative. No credit is given for future buybacks.
Market priceBackup price feed · as of 2026-10-19 14:38 UTC	$132.96	Backup price feed · as of 2026-10-19 14:38 UTC

Change SAIC's assumptions

The discount-rate dial and the editable model

Pro

Change growth, margin and WACC yourself — Pro (7-day free trial, card required).

Start free trial Try it on Apple

What does Science Applications International Corporation do?

What does it do?

Science Applications International Corporation provides technical, engineering, and mission and enterprise information technology (IT) services in the United States. It operates through two segments, Defense and Intelligence; and Civilian. It operates in the Information Technology Services industry (Technology sector), headquartered in United States. The company employs roughly 23,000 people.

How does it make money?

The business turns $7.4B in annual revenue into profit. Out of every $100 of sales, about $8 is left as operating profit (operating margin of 8.1%), after a 13% gross margin on the products/services it sells. After all costs, taxes and interest, 5.1% of revenue becomes bottom-line net profit.

Is it financially healthy?

Financially it looks stretched: carries moderate debt (1.9× equity), can just cover its short-term bills (1.2× current ratio), and is currently profitable.

Who at SAIC filed insider trades?

Recent insider filings for Science Applications International Corporation
Date	Insider	Relationship	What happened	Value	Filing
22 Sept 2026	Cush C. David	Director	Open-market buy	$132,500.00	Form 4 for Cush C. David (opens sec.gov in a new tab)
4 Sept 2026	Benson David C	Director	Grant / award	—	Form 4 for Benson David C (opens sec.gov in a new tab)
4 Sept 2026	DiFronzo Vincent P.	EVP,-Air Force & Space, Intel	Grant / award	—	Form 4 for DiFronzo Vincent P. (opens sec.gov in a new tab)
4 Sept 2026	Cush C. David	Director	Grant / award	—	Form 4 for Cush C. David (opens sec.gov in a new tab)
2 Jul 2026	DiFronzo Vincent P.	EVP,-Air Force & Space, Intel	Gift	—	Form 4 for DiFronzo Vincent P. (opens sec.gov in a new tab)
2 Jul 2026	DiFronzo Vincent P.	EVP,-Air Force & Space, Intel	Gift	—	Form 4 for DiFronzo Vincent P. (opens sec.gov in a new tab)

A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans

Common questions

What is SAIC's intrinsic value?
TickerWorth's valuation lenses put Science Applications International Corporation (SAIC) between $157.21 and $295.93 per share, versus a market price of $132.96. For a cyclical we value through the cycle we publish a range only (peer multiples and our researched mid-cycle DCF): where in the cycle the business sits decides where in that range it lands, and a single figure would claim we know that precisely.
Is SAIC overvalued or undervalued?
At $132.96 the price sits below every lens we ran. We don't call SAIC overvalued or undervalued from a range. This is an educational estimate, not advice.
What discount rate is used for SAIC?
A WACC of 7.8% and a terminal growth rate of 2.5%.
Is Science Applications International stock undervalued?
TickerWorth's fair-value range for Science Applications International Corporation (SAIC) is $157.21 – $295.93 against a market price of $132.96. Priced below our range. We publish a range here, not one number, so we do not call it over- or undervalued. This is a model estimate, not investment advice.
Science Applications International (SAIC) DCF valuation and fair value
Our fair-value range for Science Applications International Corporation (SAIC) is $157.21 – $295.93, built on a 7.8% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into Science Applications International stock?
Today's price implies revenue growth of −2.6% a year for 5 years; our model assumes 1.4% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of $132.96. A model estimate, not investment advice.
Science Applications International (SAIC) insider trading
The most recent insider filing (SEC Form 4) for Science Applications International Corporation (SAIC): Cush C. David, Director, open-market buy on 2026-09-22. The latest filings are listed on this page. A disclosure, not a signal to trade.